1 / 4

Irritable Bowel Syndrome Treatment Market by Type, End-user & Geography, 2016 - 2022

The market of irritable bowel syndrome treatment is witnessing positive growth owing to establishment of well-defined diagnosis criteria and exploration of novel therapeutic classes by the key market players.

kalpak
Download Presentation

Irritable Bowel Syndrome Treatment Market by Type, End-user & Geography, 2016 - 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Irritable Bowel Syndrome Treatment Market by Type, End-user & Geography, 2016 – 2022

  2. P e r s i s t e n c e M a r k e t R e s e a r c h About Us Persistence Market Research (PMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward- looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Each PMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With a wider scope and stratified research methodology, our syndicated reports strive to serve clients and satisfy their overall research requirement. Copyright © 2015 Persistence Market Research All Rights Reserved. This document contains highly confidential information and is the sole property of PMR. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of PMR. Irritable Bowel Syndrome Treatment Market, 2016 - 2022 Page |

  3. P e r s i s t e n c e M a r k e t R e s e a r c h Report Media Releases Irritable Bowel Syndrome Treatment Market by Type, End-user & Geography, 2016 - 2022 Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome affects the large intestine. Irritable bowel syndrome is associated with malfunctioning of the bowel and majorly occurs in elder population. Constipation, diarrhea, abdominal pain, alteration and discomfort in bowel function and bloating are some of the common symptoms of irritable bowel syndrome. Blood test and endoscopy are normally performed to detect this syndrome. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in decreasing the symptoms. Request to view TOC : http://www.persistencemarketresearch.com/toc/9938 The market of irritable bowel syndrome treatment is witnessing positive growth owing to establishment of well-defined diagnosis criteria and exploration of novel therapeutic classes by the key market players. Additionally, change in lifestyle and eating habits increases the incidence of this disorder that may escalate the use of this treatment and hence drive the market growth. However, lack of specific treatment which treat all the symptoms of this disorder may restrain the growth of this market. In addition, higher competition among the key players in terms of pricing is anticipated to hamper overall growth of this market. Irritable bowel syndrome market is classified on the basis of type, end user and geography. Based on the type, the global irritable bowel syndrome market is segmented into the following:        Irritable Bowel Syndrome with Constipation Irritable Bowel Syndrome with Diarrhea Irritable Bowel Syndrome with alternating Constipationand Diarrhea Based on the end user, the global Irritable bowel syndrome market is segmented into the following: Hospitals Clinics Homecare settings Depending on geographic regions, global irritable bowel syndrome treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Geographically, North America dominates the global irritable bowel syndrome treatment market. High degree of therapeutic needs and penetration of generic drugs in North American market is anticipated to drive the growth of this market. Meanwhile, Europe is considered as the second largest market owing to the large patient population undergoing diagnosis of irritable bowel syndrome coupled with the increasing demand for treatment. Launch of novel drugs with improved efficacy which provide sustained relief from irritable bowel syndrome in APAC region primarily drives the growth of this market. In addition, growing awareness regarding chronic nature of irritable bowel syndrome among the people will further drive the growth of this market in APAC region. Increased awareness about available treatment among the patients, medical community is one of the major driver in global irritable bowel syndrome treatment market.Increase in the number of patients, rise in the aging population, increasing demand for efficiency, increase in the incidence and prevalence of irritable bowel syndrome cases and increase in awareness, the global irritable bowel syndrome market is expected to have a healthy growth rate in the forecast period. Irritable Bowel Syndrome Treatment Market, 2016 - 2022 Page |

  4. P e r s i s t e n c e M a r k e t R e s e a r c h Various key players dominating the global irritable bowel syndrome treatment market comprise Valeant Pharmaceuticals International Inc., Sucampo Pharmaceuticals, Inc., Abbott Laboratories, Lexicon Pharmaceuticals, Salix Pharmaceuticals, Ironwood Pharmaceuticals, Inc., and GlaxoSmithKline plc. Allergan Plc. among others. The report covers exhaustive analysis on:  Irritable Bowel Syndrome Market Segments  Irritable Bowel Syndrome Market Dynamics  Historical Actual Market Size, 2013 - 2015  Irritable Bowel Syndrome Market Size & Forecast 2016 to 2022  Irritable Bowel Syndrome Current Trends/Issues/Challenges  Competition & Companies involved  Irritable Bowel Syndrome Drivers and Restraints Regional analysis includes  North America  Latin America  Europe  Asia Pacific  Middle East & Africa Request to view Sample Report : http://www.persistencemarketresearch.com/samples/9938 Report Highlights:  Shifting Industry dynamics  In-depth market segmentation  Historical, current and projected industry size Recent industry trends  Key Competition landscape  Strategies of key players and product offerings  Potential and niche segments/regions exhibiting promising growth  A neutral perspective towards market performance For information regarding permissions, contact: Persistence Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 Email: sales@persistencemarketresearch.com Website: http://www.persistencemarketresearch.com/ media@persistencemarketresearch.com Irritable Bowel Syndrome Treatment Market, 2016 - 2022 Page |

More Related